MLS® as a consolidated practice in the treatment of temporomandibular issues, in facial cranial pain and in obstructive sleep apnoea: this was confirmed by over 120 specialists who took part in the BioRESEARCH Annual Conference (12/14 July - Milwaukee, WI, USA), an international conference which focused on the latest developments in dentistry.
A well-structured scientific program was organised which, together with the seminars entrusted to luminaries such as Dr Steve Olmos – a specialist in craniofacial and SLEEP disorders and a user of MLS® Laser Therapy – also included a one-to-one section (Mentor Appointments) reserved for doctors interested in obtaining additional specifications concerning the therapies. The reference point for the "Mentor" session dedicated to lasers was Lucio Zaghetto, the ASAlaser Scientific and Educational Director.
"Of the more than 120 participants to this important Congress - explains Zaghetto - 43 have long been users of MLS®, a therapy which has become part of their daily practice thanks to the important results obtained precisely in the treatment of TMJ, Cranio Facial Pain and Sleep Apnea. An important recognition for our company which has always been at the forefront in promoting the recovery of well-being and of the best quality of life for the patient. This is confirmed by the many success stories shared by the professionals who choose us as their partner".
In addition to Laser Therapy, the conference also provided an opportunity to focus on numerous other topics of interest for doctors and dentists, such as the strategy to implement outpatient practices, the analysis of occlusions that impact on the body, the use of the bite in sports and the understanding of the functional methodologies for a correct diagnosis-therapeutic approach.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.